FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2020, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2020-10-24
DOI
10.1155/2020/5416843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor infiltrating lymphocytes: The regulator of melanoma evolution (Review)
- (2019) Mihaela Antohe et al. Oncology Letters
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
- (2019) Wylie et al. Cancers
- Turning the Tide Against Regulatory T Cells
- (2019) SeongJun Han et al. Frontiers in Oncology
- Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma
- (2019) Simona Osella-Abate et al. PATHOLOGY
- Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
- (2018) Hansje-Eva Teulings et al. OncoImmunology
- Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature
- (2018) Gyula Fekete et al. Experimental and Therapeutic Medicine
- Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance
- (2017) Phyu P Aung et al. LABORATORY INVESTIGATION
- FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer
- (2017) Shucai Yang et al. Molecular Cancer
- Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors
- (2016) SABINA ZURAC et al. Oncology Letters
- FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.
- (2015) Bee Shin Tan et al. Oncotarget
- High expression of FOXP3 in primary melanoma is associated with tumour progression
- (2013) A.L. Gerber et al. BRITISH JOURNAL OF DERMATOLOGY
- Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations
- (2013) Monica Neagu et al. Biomed Research International
- Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
- (2012) Joannes FM Jacobs et al. LANCET ONCOLOGY
- Functional crosstalk between dendritic cells and Foxp3+ regulatory T cells in the maintenance of immune tolerance
- (2012) Mara Kornete et al. Frontiers in Immunology
- Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
- (2012) Valerie Chew et al. Journal of Oncology
- Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction
- (2011) Junzhou Niu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice
- (2011) Claus Garbe et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- The dual role of the X-linked FoxP3 gene in human cancers
- (2011) Margaret Redpath et al. Molecular Oncology
- Human FOXP3 and cancer
- (2010) F Martin et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started